Maximum Tolerated Dose of PEG-interferon Alfa-2b and Sorafenib Tosylate up to 2 months [clinicaltrials_resource:ca25ae66b963ed544aeb7884b4253e08]
Peginterferon alfa-2b will be administered SC on day 1 of each week of therapy. This will most likely be a Monday or a Tuesday. Sorafenib will be initiated on day 15 (start of week 3) of the first course and continued daily without breaks.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Maximum Tolerated Dose of PEG-interferon Alfa-2b and Sorafenib Tosylate up to 2 months [clinicaltrials_resource:ca25ae66b963ed544aeb7884b4253e08]
Peginterferon alfa-2b will be administered SC on day 1 of each week of therapy. This will most likely be a Monday or a Tuesday. Sorafenib will be initiated on day 15 (start of week 3) of the first course and continued daily without breaks.
Bio2RDF identifier
ca25ae66b963ed544aeb7884b4253e08
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ca25ae66b963ed544aeb7884b4253e08
measure [clinicaltrials_vocabulary:measure]
Maximum Tolerated Dose of PEG-interferon Alfa-2b and Sorafenib Tosylate
time frame [clinicaltrials_vocabulary:time-frame]
up to 2 months
description
Peginterferon alfa-2b will be ...... ontinued daily without breaks.
identifier
clinicaltrials_resource:ca25ae66b963ed544aeb7884b4253e08
title
Maximum Tolerated Dose of PEG-interferon Alfa-2b and Sorafenib Tosylate up to 2 months
@en
type
label
Maximum Tolerated Dose of PEG- ...... 5ae66b963ed544aeb7884b4253e08]
@en